We had a new visitor in the Spectrum office today, but he’s coming back for good at the beginning of 2014. We’re excited about this next big step for Spectrum!
Spectrum today announced Jonathan Wilson has been named the new President of the leading health and life science public relations firm, based in Washington, DC.
Mr. Wilson resigned as President of Chamberlain Healthcare Public Relations in New York, and is relocating to Washington with his family.
Spectrum founder John Seng continues as Spectrum’s CEO, and will assume the new title of Chairman of Spectrum Science Communications, Inc. He also retains his position as Chair of the GLOBALHealthPR partnership that he co-founded in 2001, after establishing Spectrum in 1996.
CEO and Chairman John J. Seng; Senior Vice President Lissette Capati; President Jonathan Wilson; Senior Vice President Maureen Varnon
Spectrum announced today the promotion of Lissette Capati to Senior Vice President and Megan Lustig to Vice President. Capati and Lustig will continue to lead key accounts, advising Spectrum clients on strategic messaging, public affairs, issues management and corporate and product communications, while assuming greater responsibility for the firm’s business and staff development efforts. (more…)
Here at 2001 Pennsylvania Avenue, we have something called The Spectrum Way. It’s sort of like Spectrum’s list of commandments. Our ability to help clients achieve their business goals is a result of this working philosophy. What’s the result of these guidelines? Check it out:
Spectrum announced today the promotions of Liz Bryan and Luke Dickinson to Vice President. Bryan and Dickinson will continue to lead key accounts in Spectrum’s portfolio of clients focused on consumer products, biopharmaceutical development and academic research, while assuming greater responsibility for the firm’s business and staff development efforts. (more…)
Senior health care communications professional Rosalba Cano has rejoined Spectrum, one of the nation’s leading independent health and science communication firms. As vice president, Rosalba will provide counsel to pharma, biotech and non-profit clients on communications programs and will lead scientific communications efforts for a global consumer products company, as well as lead specific business development efforts. (more…)
This past Wednesday night, Spectrum shared a little science and magic with friends, family, clients and others to celebrate the successful transition to our new home on Pennsylvania Avenue. The evening’s theme was “Magic and Science,” and we had fun with science-themed music, fare and a little abracadabra.
We wanted to show guests just how magical the field of science and health communications can be. Beaker-shaped cookies completed the dessert table and a mixologist extraordinaire served Spectrum green cocktails in test tubes. Guests chatted with one another as a DJ played a collection of our favorite songs, and we were all dazzled by another performer, Barry the Magician. With card tricks, telepathy and an appearing live dove, the show was definitely on!
Spectrum’s office has transformed into a space that demonstrates who we are and how we work – collaboratively! We hope our unique working style and zest for creativity was evident. And we hope everyone enjoyed the open house party!
Living in D.C., it’s common to hear “who do you work for?” and “what do you do?” I often respond with “well, I mostly like to plan for travel, watch SEC football and invest in friends.” Since people expect you to say something about working on the Hill for Congressman so-and-so, my reply either elicits a confused look or opens the door for a real, personal conversation. The truth is, it’s challenging to explain what I do in just a few words, as evident based on my title: Executive Business Development and Marketing Assistant. (more…)
A few weeks ago, Frannie asked me if there was anything she could help me with, and I nonchalantly replied, “I don’t know, get me in THE NEW YORK TIMES.” She didn’t forget, and I’m reminded of what a winner she is! Check out The Money Shot.
My colleague shared an amazing video earlier this week called “The Science of Love.” After watching the video, all I could think about was an interaction between two of my favorite characters from my guilty pleasure TV show, Bones. In a juxtaposition of traditional gender rolls, Special Agent Seeley Booth is the lovey-dovey type, whilst Dr. Temperance Brennan is all hard logic.
Booth: “Oh, I’m just saying that life is a lot more than what you cook up with your chemistry sets. Miracles do happen.” Brennan: ”Love is a chemical process which causes delusion.”
And, of course, Dr. B is right. According to our friends at AsapSCIENCE, a brain in love acts pretty much the same as a brain on cocaine. Apparently the dopamine rush you experience begins to set off “pleasure centers” in your brain allowing you to create a “romanticized view of the world around you.” Interesting stuff right?
There’s more. AsapSCIENCE explains that romantic love is not just an emotion, but is driven directly from the brain, and not so much your heart. It is also found that people in love have low levels of serotonin, which is also similar to those individuals with Over Compulsive Disorder. Hence the infatuation feeling in the “honeymoon phase” of love.
Scientist don’t have it all figured out yet and still have a lot to learn about love. So there is also truth in Agent Booth’s belief in that life [and love] is a lot more than just chemistry.
Happy Valentine’s Day all! Check out the video by AsapSCIENCE above. Let us know what YOU think about The Science of Love, comment below!
Earlier today, I had the opportunity to attend a meeting at the Georgia BIO Leaders Breakfast. Despite the rain and potential hazard of Atlanta traffic, the room was packed and ready to hear insights from Arbor Pharmaceuticals’ President and CEO, Ed Schutter. The format was an informal Q&A about how Mr. Schutter came to Atlanta from Chicago, studied to be a pharmacist at Mercer University, and found a love for science, medicine and business. What better way to combine all these interests than to work in the pharmaceutical business?